A graphical method is described that allows the determination of specific radioactivites of radioactively labelled hormones. This method combines the self-displacement technique, plotting bound/free ratios versus mass of unlabelled hormone or total radioactivity of labelled preparation added to the receptor preparation, and the maximal binding capacity of the labelled hormone. The procedure presented herein provides a more realistic specific radioactivity for use in all binding experiments. Application of the method is demonstrated for '25I-labelled ovine prolactin, and data are presented for 125I-labelled human choriogonadotropin and PHitestosterone.
Hormone binding studies are performed with radioactively labelled hormones and it is necessary to know their specific radioactivities in order to obtain the binding parameters such as affinity constant and binding sites in terms of concentration. Until now, most of the investigators obtained the specific radioactivity data from purification steps after hormone labelling, data that represent a source of error because, as has been demonstrated for insulin (Cresto et al., 1981) , the iodination procedure may yield monoiodinated hormone, as well as di-or non-iodinated molecules, and, unless one could purify the different fractions, the specific radioactivity thus obtained represents an average from different species, not all with the same biological activity.
Other authors have used a self-displacement technique to obtain a more realistic specific radioactivity (Catt et al., 1974; Moyle et al., 1980) , which assumes that the mass of the tracer in the labelled stock solution was that which gave an equal B/F ratio as unlabelled hormone in a plot of B/F versus log [mass (ng) unlabelled hormone] or volume (,l) of 125I-labelled hormone. This assumption is true only when the mass of the tracer is negligible compared with that of the unlabelled hormone added, as will be proved in the present paper.
Abbreviation used: B/F ratio, ratio of bound hormone to free hormone.
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In the present work we provide a useful and simple technique to obtain specific radioactivities of labelled hormones which uses the self-displacement method, and present a detailed description of the procedures employed and the mathematical principles involved.
Materials and methods Iodination ofovine prolactin
Ovine prolactin (NIH-P-S 12) was iodinated with Na'251 (New England Nuclear NEZ-033A; carrierfree; 17 Ci/mg), at room temperature by using the lactoperoxidase/perhydrol method of Thorell & Johansson (1971) , except that the reaction was allowed to proceed at pH 7.4 for 2 min. A first fractionation of the iodinated hormone was carried out on a column (0.5 cm x 20 cm) of Sephadex G-75 equilibrated with 50mM-sodium phosphate buffer, pH 7.5, containing 0.2% bovine serum albumin (Sigma, fraction V), 100mM-NaCl and 0.05% NaN3.
Binding experiments
Ventral At the end of the reaction the incubation mixture was diluted with 2ml of cold phosphate-buffered saline and the tubes were centrifuged at 50OOg at 2-40C for 15min. The pellets were washed twice with the same buffer, re-centrifuged as above, and the radioactivity in the remaining pellets was determined with a Beckman Auto-Gamma 4000 spectrometer with 60% efficiency.
There were no losses during washing, as evaluated by protein determination by the Lowry method. There was complete recovery of bound radioactivity in the pellet as evaluated by washing a known amount of bound radioactivity pipetted into a clean tube.
In order to obtain the maximal binding capacity of the labelled hormone preparation, different samples of the membrane preparation were equilibrated with approx. 30000c.p.m. of labelled hormone and the non-specific binding was obtained from the radioactivity bound in the presence of 5,ug of unlabelled ovine prolactin. From the ordinate intercept of a plot of 1/(radioactivity specifically bound) versus 1/(receptor volume added) it was possible to determine the fraction of ovine prolactin that would bind at infinite acceptor concentration (maximal binding capacity). Other binding studies Human choriogonadotropin (kindly provided by Dr. E. Passeron, Laboratorios Elea, Buenos Aires, Argentina) (11 000 i.u./mg) was labelled as described for ovine prolactin and similar binding experiments were conducted with a collagenase-dispersed Leydigcell preparation (Mendelson et al., 1975) as receptor source.
For 11,2-3H(n)Itestosterone (NET-387; 40-60Ci/ mmol; New England Nuclear), the binding studies were performed with a specific antibody (obtained in our laboratories by active immunization of rabbit with bovine-albumin-coupled testosterone) as receptor system, and again two sets of experiments were performed, one with different concentrations of labelled hormone and the other with various masses of unlabelled testosterone.
In both cases, human choriogonadotropin and testosterone, the maximal binding capacity was 100%.
Description and application ofthe method
When only a single order of reaction sites is present, one may write the following Scatchard (1949) (Ekins et al., 1968) and B/F versus total radioactivity (c.p.m.) added to the incubation mixture.
If the receptor system is the same in both cases, that is, the same K and q parameters apply (which is always true when the same receptor or antibody preparation are used and when both experiments are performed at the same time), and the radioactive as well as the unlabelled hormone show identical binding behaviour, then, for a given B/F value the mass of hormone bound to the receptor must be the same in each case. The equation that reflects this statement is:
where, for the first experiment, B1 is radioactivity specifically bound, T1 is (total radioactivity-nonspecific radioactivity) x maximal binding capacity, 
From eqn. (2):
The original assumption was that:
where F1 is the amount of free hormone (T1-B1) and (8) Fraction no. Fig. 1 . Purification of 125I-labelled ovine prolactin (12S5-oPrl) through a Sephadex G-75 column Iodination mixture was applied to a column (0.5 cm x 20cm) of Sephadex G-75 equilibrated with 50mM-phosphate buffer pH 7.5, containing 0.2% bovine serum albumin, lOOmM-NaCl and 0.05% NaN3. In all, 20 fractions were collected and two peaks (labelled hormone and free 1251) were distinguished. Specific radioactivity calculated from the elution profile was 32.6,uCi/,g. specific radioactivity of this hormone preparation [calculated from the labelling efficiency (96%) obtained from the elution profile] was 32.6,uCi/,ug. Fig. 2 shows the self-displacement assay in which unlabelled ovine prolactin or the radioactive preparation were varied and the B/F ratios calculated in both cases. For reasons that will be discussed further, a maximal binding capacity of 100% was assumed.
From these representations and using a B/F range from 0.08 to 0.045 we obtained T1 and p and plotted them as shown in Fig. 3 . The specific radioactivity, calculated from the slope of this line, was 33.3,uCi/ pg, which is in good agreement with the abovementioned value of 32.6,uCi/pg.
But, as we discussed in the introduction, this is not the real value, but an average of different specific radioactivities from labelled molecules. In order to obtain the more accurate specific radioactivity we considered the maximal binding capacity of the hormone preparation. 1/(Receptor volume added) (ml-) Fig. 4 . Determination of the maximal binding capacity of the radioactive hormone preparation Five portions of receptor preparation were incubated with a fixed amount of 125I-labelled ovine prolactin (approx. 30000c.p.m.) and l/(radioactivity specifically bound, B) was plotted versus 1/(receptor volume added). From the ordinate intercept of the graph the fraction of the ovine prolactin that would bind at infinite acceptor concentration was determined and found to be 64% of the total radioactivity added.
the new total radioactivity added (Fig. 5) and by using these plots and the straight line obtained from them, we calculated a specific radioactivity of 12.4,Ci/,g.
In order to observe the effect of considering one specific radioactivity or the other, we performed the corresponding Scatchard plots (Fig. 6 ) using the B/F ratios and the specific radioactivity bound when radioactive hormone was the variable. It can be observed that the affinity constant is maintained (Ka = 5.4 x 109M-1 for sp. radioactivity = 33.3 #Ci/#g, and K. = 4.7 x 109M-1 for sp. radioactivity = 12.4,uCi/,ug), but there is a We propose to use as specific radioactivity that obtained by self-displacement analysis (which provides the true mass of active tracer, calculated from the competition studies), using the maximal binding capacity (the real radioactivity corresponding to the tracer mass) for all the binding studies.
The values obtained for 125I-labelled human choriogonadotropin, using rat Leydig cells as receptor system, and for [3H]testosterone, utilizing a specific antibody, are as follows: for human choriogonadotropin, the specific radioactivity determined by the elution profile of the column chromatoVol. 212 graphy after its labelling was 12.5 uCi/4ug, whereas the result obtained by the method described herein was 11.5 uCi/,ug. On the other hand, the results for [3Hltestosterone were: 36.0 Ci/nmol, when the specific radioactivity was calculated from data obtained from New England Nuclear (4060 Ci/ mmol), recalculated for the 3H decay, and 37.0Ci/ mmol when the self-displacement technique was utilized. In both cases a maximal binding capacity of 100% was considered.
These results confirmed the method proposed and also provided evidence that it may be used for peptide and steroid hormones and in radioligandreceptor assays as well as in radioimmunoassay experiments.
